GlaxoSmithKline invests $300M in genetics research
Wednesday, July 25, 2018 - 12:33
in Mathematics & Economics
British pharmaceutical company GlaxoSmith Kline announced Wednesday a $300 million investment and partnership with California-based genetics company 23andMe.